Polyphenols

This page as PDF · Summary

1. What Polyphenols Are

Polyphenols are secondary plant compounds with multiple phenolic hydroxyl groups. They include, among others, the flavonoids as well as further subgroups that differ markedly in structure, size and solubility. Decisive for research is that the term denotes an entire substance class and not a single compound. Anyone reading about polyphenols encounters, depending on the study, flavonoids, the totality of phenolic compounds of a plant or the composition of an extract. Individual foods, teas and juices, extracts and preparations manufactured from them are investigated. Every reliable statement must therefore name which material was tested and in which preparation.

One point is decisive for the assessment of all studies: polyphenols are scarcely absorbed unchanged. A large proportion is metabolised in the large intestine by the gut flora and subsequently further modified in the liver; predominantly degradation products are present in the blood, not the original compound. One of the most frequently cited studies in the field deals precisely with how the gut flora co-determines absorption and the observed effects. Plausible: It follows for the reading of every study that the administered substance is rarely measured and that the absorbed amount depends on the substance, the food matrix and the individual gut flora. The measurement level also comes into play. Many controlled studies record lipid values, oxidative stress parameters or questionnaire scores; others examine cognitive performance. Markers and disease course are not the same. When comparing results, substance, material, preparation and measured variable must be placed side by side.

2. What the Studies Show in Detail

The supporting human studies and the most important reviews — by field of application, with population, duration, preparation, measured variable and result, as the original studies report them. Numbers appear only where the study states them.

Distribution of controlled human studies by field of application — the numbers are not additive, as one study may be assigned to several fields:

Oxidative Stress

A randomised, double-blind, placebo-controlled crossover study tested a capsule concentrate from fruit, vegetable and berry juice powders (Juice Plus+ Premium®) in 92 participants over two periods of 16 weeks each, separated by a four-week wash-out phase 22. Stroop test, Trail Making Test and Reynolds Intellectual Screening Test as well as CREB and BDNF in plasma were measured by ELISA. Under the polyphenol-rich preparation the Stroop and RIST values were higher than under placebo, and CREB and BDNF in plasma were markedly elevated 22. The study interprets the finding as modulation of neurobiological mechanisms; the abstract does not state effect sizes.

24 trained participants received 250 mL jaboticaba berry juice with approximately 1300 mg total polyphenols or a fruit-flavoured placebo for seven days 40. On the fourth day, 6 × 10 maximum isokinetic eccentric contractions of the elbow flexors followed. The protocol increased myoglobin (p < 0.001) and muscle soreness (p < 0.001) and lowered reduced glutathione (p < 0.001), maximum isokinetic voluntary contraction (p < 0.001), functional (p < 0.001) and morphological muscle quality (p = 0.028). The juice increased GSH (p = 0.001), lowered muscle soreness (p = 0.041) and accelerated recovery of muscle strength (p = 0.004) 40. The small group and the short period limit the statement.

30 participants with borderline diabetes drank a tea made from mulberry leaves and water chestnut shell in a randomised, double-blind, placebo-controlled crossover comparison study 38. The test meal of 3 g contained 10.2 ± 0.8 mg 1-deoxynojirimycin and 61.3 ± 1.4 mg total polyphenols and showed higher antioxidant activity than the placebo. Blood glucose was significantly lower 30 and 60 minutes after the rice meal, insulin at all time points (30, 60, 90 and 120 minutes) 38. A systematic review evaluated 13 studies with 640 patients with hyperlipidaemia; 12 commonly consumed food groups as well as medicinal and food plants were recorded 3. All 13 studies reported on blood lipids, significant improvements were shown for 9 foods, and eight studies additionally examined oxidative status 3.

251 participants with increased waist circumference were randomised in a secondary analysis of the Habitual Diet and Avocado Trial to daily avocado or avoidance for six months, without additional dietary counselling 19. Memory, processing speed, executive function, simple reaction time and working memory reaction time were recorded at baseline and at the end of the intervention; the abstract does not state the results 19. The review article on polyphenolic compounds screened approximately 141 works from 1979 to 2025 on sources, extraction, purification and antioxidant mechanisms from radical scavenging to modulation of signalling pathways and names open questions in clinical validation and formulation 45. A second review describes catechols that act antioxidatively and simultaneously generate controlled reactive oxygen species, and their application in materials, antimicrobial strategies, cancer therapy and tissue regeneration; pharmacokinetics, biosafety, regulation and manufacturing consistency stand in the way of clinical translation 46. What is missing are human studies that jointly measure uptake, metabolism and oxidative status over longer periods.

Inflammatory Processes

A systematic review with meta-analysis on dietary polyphenol preparations in COPD searched PubMed, Cochrane, Medline, CNKI and further databases up to 26 December 2024 for Chinese and English works 1. In connection with the included studies, a triple-blind, placebo-controlled design in patients at GOLD stages II–III with 8-isoprostane and course parameters of lung function is described; the pathways mentioned are an increase in the GSH/GSSG ratio and attenuation of NF-κB-mediated inflammatory cascades, and as lung function parameter an FEV1 improvement of at least 12 % versus baseline 1. The abstract ends before the pooled results; heterogeneity between the included randomised studies remains the open point there.

BMI, ALT, AST, triglycerides, total cholesterol, HDL-C, LDL-C and TNF-α were assessed. Naringenin lowered total cholesterol (SUCRA 94.59 %) and triglycerides (99.00 %); catechin lowered BMI (77.74 %), ALT (94.21 %), AST (93.56 %) and total cholesterol (92.26 %) and raised HDL-C (93.72 %) 2. The ranking is based on indirect comparisons; the abstract ends before the data on dihydromyricetin.

A systematic review on polyphenol-rich seed foods in coronary heart disease included seven studies with 324 patients and three seeds: Brazil nut, almond and linseed 11. The meta-analysis showed a significant reduction in triglycerides (MD = −20.03) 11; the confidence interval is cut off in the abstract. 50 patients with hyperlipidaemia received in a single-blind, randomised clinical study for four weeks either a higher-dose, lower-polyphenol native olive oil (414 mg/kg phenols, 20 g/day) or a lower-dose, higher-polyphenol one (1021 mg/kg phenols, 8 g/day), so that daily polyphenol intake was approximately 8.3 mg in both groups 34. In addition, 20 healthy persons in two groups received the same oils over the same period. Primary endpoints were total cholesterol, LDL, HDL, triglycerides, lipoprotein(a) as well as apolipoprotein A1 and B, measured at baseline and at the end 34; the abstract does not state the results.

In a two-phase population trial, 151 persons were first examined; the median microplastic concentration in stool was 158.28 µg/g dry weight and correlated with seven inflammation indices, four cytokines and two lipid markers 20. In the subsequent 28-day randomised, double-blind, placebo-controlled phase with 98 participants, composite polyphenols lowered IL-1β (P = 0.045, effect size −0.463), IL-6 (P = 0.023, −0.576) and IL-8 (P = 0.022, −0.529) 20. Between high and low exposure, 507 differentially expressed microbiota and 144 different metabolites were found; after the intervention 108 and 85 respectively 20. 100 healthy women aged 25 to 64 years in rural communities of Puno, Peru, were followed for twelve months; the analysis used data from the Cardiopulmonary Outcomes and Household Air Pollution Study 42. Mean age was 49 ± 10 years, mean total polyphenol intake 335 ± 193 mg/day, collected via 24-hour recalls and the Phenol-Explorer database. IL-10, IL-6, IL-1β, C-reactive protein, TNF-α as well as VCAM-1 and ICAM-1 from dried blood spots were measured 42; the abstract ends before the regression results. What is missing are studies that link intake and inflammatory markers in an adequate number of participants with pre-specified endpoints.

Metabolism

In a four-week, parallel, double-blind exploratory study, 50 patients with HIV and elevated triglycerides each received two doses of tamarind fruit juice 39. Eligible persons were aged 30 to 60 years with triglycerides of 150 mg/dL or higher. 600 mL juice was drunk daily, with 10 % or 30 % fruit pulp, corresponding to 1556 mg and 1631 mg analysed polyphenols respectively. The primary endpoint was triglycerides; blood pressure and vascular function were also measured, and participants were asked to maintain their usual diet and lifestyle 39.

The juice with 30 % fruit pulp lowered triglycerides by −39.8 mg/dL (95 % CI: −67.7 to −11.9) 39. Analysis was by intention-to-treat; the study is registered under NCT06058845. Food intake, background polyphenol intake and physical activity were also recorded 39. What is missing is a replication with a larger number of participants and longer duration that examines vascular function as a pre-specified endpoint.

Further Studies

A systematic review examined the association between phytochemicals — polyphenols, carotenoids and phytoestrogens — and outcomes of assisted reproductive technologies 12. PubMed, Scopus, Web of Science and Clinical Trials were searched from January 1978 to March 2023. Included were observational, randomised controlled and cohort studies; 13 works were admitted, among them five randomised controlled trials, one non-randomised controlled study and six prospective cohort studies 12.

Live birth rate, clinical pregnancy and ongoing pregnancy were recorded. Quality of the included works was assessed independently by two investigators using the Quality Criteria Checklist for Primary Research 12. The abstract ends before the summarised results. What is missing is an analysis that reports the three endpoints separately and with participant numbers.

Gut and Microbiome

A review describes that the bioactivity of polyphenols depends strongly on the amount ingested and on the interaction with the gastrointestinal tract and the gut microbiota 43. Only a portion is absorbed in the small intestine, where enzymatic hydrolysis releases aglycones; a considerable proportion reaches the large intestine, where microbes convert them into simpler phenolic metabolites that are often more bioavailable and enter the systemic circulation 43. Even low intake or poor absorption can have an effect because polyphenols in the large intestine alter the composition and function of the microbiota; the review places these interactions along the gut–liver–brain axis.

A review evaluated studies on the question of whether encapsulation improves the bioavailability of polyphenols 33. Clinical evidence focuses on polyphenols from grape pomace, cocoa and blueberries as well as on individual compounds such as fisetin, hesperidin and curcumin; encapsulation proved effective 33. The majority of the evidence on bioavailability after digestion comes from in-vitro studies that cannot represent physiological conditions and the microbial ecosystem 33.

A review on nuts describes their content of unsaturated fatty acids, fibre, minerals, vitamins as well as polyphenols and phytosterols and places the bioaccessibility of nut polyphenols and their interaction with the gut microbiota 41. Observational cohorts and randomised clinical studies consistently report favourable associations with lower risk of obesity, hypertension, elevated LDL cholesterol, cardiovascular diseases, especially coronary heart disease, and cancer 41. What is missing are intervention studies that measure the intake of the polyphenols and not only nut intake overall.

Cognition and Psyche

A systematic meta-analysis of randomised controlled studies examined cognitive and further endpoints in neurodegenerative diseases under polyphenol administration 4. Various polyphenol types across seven neurodegenerative diseases were evaluated; 13 studies with 849 participants were included. Pre-specified endpoints were global cognition (MMSE), domain-specific cognition (ADCS-Cog), activities of daily living (ADCS-ADL), neuropsychiatric symptoms (NPI) as well as plasma amyloid-β40 and BDNF 4. Reporting followed PRISMA 2020, methods followed the Cochrane Handbook, certainty of evidence was assessed with GRADE.

Polyphenol administration was associated with improved global cognition (pooled MD in MMSE = 2.06; 95 % CI 0.62–3.49) 4. In subgroups, flavonoids showed a modest but significant improvement in MMSE values, while stilbenes showed markedly improved ADCS-ADL values, without clear gains in MMSE or ADCS-Cog and without a uniform effect on the NPI. Anthocyanidins, phenolic acids and lignans did not significantly influence the cognitive endpoints 4. What is missing are studies that directly compare the individual polyphenol classes against each other and against placebo.

Overall Picture

Across the fields, two types of work contribute: randomised controlled studies with concrete endpoints and reviews that bundle many individual studies. Individual studies show results for polyphenol-rich preparations and whole fruits: higher Stroop and RIST values with elevated CREB and BDNF in 92 participants after intake of polyphenol-rich preparations 22, −39.8 mg/dL lower triglycerides in 50 patients with HIV after intake of tamarind 39, elevated GSH and faster strength recovery in 24 trained persons after consumption of jaboticaba berries 40.

Where the evidence is open, it is usually due to the number of participants, the duration or abstracts ending before the results — as in the avocado study with 251 participants 19, the olive oil study with 50 patients 34 and the COPD review 1. Bioavailability remains the consistent bottleneck: reviews on encapsulation 33, on microbiota-mediated conversion 43 and on liposomal systems 44 name it as the central hurdle. What is missing are long, independently funded studies that jointly measure intake, metabolites and clinical endpoints.

3. How Robust the Research Is

The research is clearly basic-science oriented. The largest block consists of mechanistic and foundational studies, followed by reviews on mechanisms of action; together they far outnumber human studies. Cell-culture and animal studies are also numerous, as are environmental and agricultural studies on production and characterisation. In humans, observational studies stand alongside controlled studies. Within the controlled studies the emphasis lies on metabolism and safety, followed by antioxidant markers and inflammation. Cardiovascular, fatigue, gut and cognition follow at a distance; the rarest are studies on bioavailability and oncology. Foundational studies supply the mechanistic logic; clinical studies test individual sections of it.

Proven For chronic obstructive pulmonary disease and for non-alcoholic fatty liver disease there are reviews with meta-analysis that pool several controlled studies; they permit statements about the group of polyphenols, not about an individual substance. Many individual studies are randomised, double-blind and placebo-controlled, some in crossover design, which increases comparability. The weakness lies in the dispersion of the material: foods, teas, extracts and supplements differ in composition and form of administration, follow-up periods are mostly short, and a substantial proportion of the studies report markers rather than clinical endpoints. Observational studies show associations, not causation. No effect of a single polyphenol can be derived from mixture studies.

4. What Is Frequently Claimed — and What the Data Support

5. Profile: Molecule and Charge

Polyphenols are not a single molecule but a mixture — there is no sum formula and no fixed molecular mass. What can be described are functional groups, charge behaviour and redox properties; that is exactly what the next section addresses.

6. Charge, Electrons, Radicals

At the centre stands the catechol/o-quinone-hydroquinone/p-quinone cycle with NQO1 and Keap1/NRF2 thresholds 23. Polyphenols are thereby understood as modulators of redox signalling, not as mere radical scavengers 23. The quinone species determines safety: reactive quinone intermediates bind protein thiols, deplete glutathione and raise reactive oxygen species 25; alongside these stand metal-ion chelation and interventions in cytochrome P450 25. Food processing such as PPO-induced browning shifts the quinone pools 23. In the ABTS assay hydrogels reached a radical-scavenging rate of 96.51 % 27.

In humans, signalling pathways and safety questions have been examined. Human findings are classified as redox signalling 23; under cytotoxic chemotherapy the simultaneous administration of antioxidants correlated with increased disease recurrence and mortality 16. Significant reductions in extracellular DNA, reactive oxygen species or MPO signals do not constitute proof of clinical efficacy in humans 24. In human tissue APEx reached 977.08 ± 15.73 mmol Trolox/100 g in vitro and lowered reactive oxygen species and inflammatory cytokines 26. It remains to be tested whether metabotype-appropriate strategies and control of the quinone species hold in humans 23.

7. Interactions with Other Substances

With which other substances on the platform this substance has been jointly investigated or discussed in human studies and reviews — combination, comparison or shared pathway. The number indicates studies in which both appear.

Encapsulation is being examined as a strategy to improve the stability and bioavailability of polyphenols 33; for individual polyphenols such as hesperidin, fisetin and curcumin it is considered an effective technique 33. Whether it increases bioavailability in humans remains formulated as a question 33. Combinations with exercise in overweight adults with prediabetes are investigated in a controlled study 28, synergistic effects with standard lipid-lowering agents are to be examined in large, long-term randomised studies 5. Synergies with radiation and chemotherapy are also discussed 29.

One study compared polyphenol-microbiota interactions in stool samples from healthy individuals (n = 3), from patients with ulcerative colitis (n = 3) and with Crohn's disease (n = 3) in an in vitro fermentation model with 16S rRNA sequencing 32. Synergistic effects with non-polyphenolic compounds are described for inflammatory enzymes, pro-inflammatory cytokines and oestrogen receptors as well as signalling pathways such as NF-κB and PI3K/AKT, according to preclinical and clinical studies 30. Antibiotic adjuvant and nanotransport are considered future research 31. It remains open whether polyphenols alter CYP enzymes or plasma protein binding.

8. Overdosage, Tolerability, Limits

In a controlled human study, 8–20 g EVOO per day was described as well tolerated 34. A polyphenol-rich extract from S. ramosissima showed an acceptable safety profile in patients with lacunar infarction over long-term use; the authors classify the findings as hypothesis-generating, not as evidence of efficacy 35. A VF extract was well tolerated, without adverse clinical events or biochemical changes in liver and kidney function; clinical symptoms, liver and kidney values and urinary KIM-1 were examined 36.

In ulcerative colitis, a meta-analysis of randomised controlled trials found no significant differences in adverse effects (ITT: OR 0.99; 95 % CI 0.56–1.76; P = .973; PP: OR 0.99; 95 % CI 0.54–1.80; P = .971) 9. A randomised, double-blind, placebo-controlled crossover trial with 31 participants over two weeks examined safety via hypoglycaemia parameters of glucose measurement and blood values; use of MW tea was considered without safety concerns 373737. Data on upper limits, toxicity thresholds and contraindications are still absent from the evaluated evidence. What would need to be examined is which dose of polyphenol-containing preparations should be regarded as the upper limit and how safety presents itself with longer administration.

9. The Most Robust Studies

Ordered by strength of evidence, not by prominence: reviews and studies with many participants first. The complete evaluation comprises significantly more studies; the most robust ones are listed here.

Controlled Studies in Humans

• 1 Efficacy and safety of dietary polyphenol supplements for COPD: a systematic review and meta-analysis (2025) — Systematic review, 894 participants
• 2 Efficacy of dietary polyphenol supplement in patients with non-alcoholic fatty liver disease: a network meta-analysis (2025) — Systematic review, 3.132 participants
• 3 Effects of Polyphenol-Rich Foods on Lipids and Oxidative Stress Status in Patients with Hyperlipidemia: A Systematic Review of Randomized Controlled … (2024) — Systematic review, 640 participants
• 4 Polyphenol consumption and neurodegeneration risk: a systematic meta-analysis of randomized controlled trials bridging nutrition and cognitive health (2026) — Systematic review, 849 participants
• 5 An updated systematic review and meta-analysis of pomegranate consumption on lipid profile (2025) — Systematic review, 2.695 participants
• 6 Olive oil consumption and risk of breast cancer: Prospective results from the Moli-sani Study, and a systematic review of observational studies and … (2025) — Systematic review, 11.442 participants
• 7 The effect of asparagus stem consumption on health outcomes in adults: a systematic review (2026) — Systematic review, 503 participants
• 8 Pomegranate juice consumption and lipid profile: An updated systematic review and meta-analysis (2026) — Systematic review, 663 participants
• 9 Efficacy of polyphenols in adjuvant treating ulcerative colitis: A meta-analysis of randomized controlled trials (2025) — Systematic review, 742 participants
• 10 Efficacy of antioxidants as a therapy for Alzheimer's disease: a meta-analysis (2026) — Systematic review, 10.537 participants
• 11 Effects of polyphenol-rich seed foods on lipid and inflammatory markers in patients with coronary heart disease: a systematic review (2024) — Systematic review, 324 participants
• 12 How phytochemicals influence reproductive outcomes in women receiving assisted reproductive techniques: a systematic review (2025) — Systematic review
• 13 Association between polyphenols and inhalation-induced oxidative stress in chronic lung diseases: A systematic review (2026) — Systematic review
• 14 The Effect of Polyphenol Supplementation in People with Multiple Sclerosis: A Systematic Review of Clinical Trials (2026) — Systematic review
• 15 Dietary polyphenol intake in the prevention and management of diabetes mellitus: a systematic review of observational studies (2026) — Systematic review
• 16 Impact of Nutritional Supplements and Antioxidants in the Treatment of Breast Cancer: A Systematic Review (2026) — Systematic review
• 17 Effects of carob (Ceratonia siliqua) and carob-derived products on glycaemic control and insulin resistance: A systematic review of clinical trials (2026) — Systematic review
• 18 Exploring the effect of avocado on lipid profile modulation: a systematic review and dose-response and meta-analysis of clinical trials (2026) — Systematic review
• 19 Effects of one avocado a day for six months on cognitive performance in overweight adults: A randomized controlled trial (2026) — 251 participants
• 20 Composite polyphenols mitigate microplastic exposure-related immune disturbances: a two-phase population trial (2026) — 151 participants
• 21 Efficacy of Hibiscus sabdariffa L. extract on metabolic parameters in participants with abdominal obesity and mild metabolic syndrome in Bangkok … (2025) — 108 participants
• Impact of the gut microbiome on health impacts of Haskap berries: study protocol for a randomized control trial (2026) — 120 participants
• 22 Impact of Polyphenol-Rich Nutraceuticals on Cognitive Function and Neuroprotective Biomarkers: A Randomized, Double-Blind, Placebo-Controlled … (2025) — 92 participants
• From laboratory to clinic: opportunities and challenges of functional food active ingredients in cancer therapy (2025)

10. Summary

Research is clearly basic-oriented: mechanistic studies and reviews on mechanisms of action outnumber human studies many times over. Within controlled human studies, the focus lies on metabolism (38), safety and tolerability (27), oxidative stress (26) and inflammatory processes (25); cardiovascular system (18), fatigue and stress (17), gut and microbiome (14) as well as cognition and psyche (14) follow at a distance, whereby the numbers are not additive. The review articles with meta-analysis on COPD and non-alcoholic fatty liver as well as the meta-analysis on polyphenol-rich seed foods in coronary heart disease, which significantly lowered triglycerides, are considered robust.

Plausible Polyphenols are scarcely absorbed unchanged. Rarely is the administered substance itself measured; the absorbed amount depends on the substance, food matrix and individual gut flora. Hypothesis: Because microbial metabolites are often better available and the review places these interactions along the gut-liver-brain axis, part of the observed effects could be attributable to degradation products rather than the parent compound. In human in-vivo studies, encapsulation proved effective for the bioavailability of polyphenols from grape pomace, cocoa and blueberries as well as of fisetin, hesperidin and curcumin.

What a study would need to clarify is the joint measurement of absorption, metabolism and oxidative status over longer periods in humans. For assisted reproduction, an evaluation reporting live birth rate, clinical and ongoing pregnancy separately and with participant numbers is pending. For nuts, intervention studies that measure polyphenol intake rather than nut intake overall remain open. For tamarind juice, a replication with larger participant numbers and longer duration that examines vascular function as a pre-specified endpoint is pending. For COPD, heterogeneity between the included randomised studies remains the open point that the pooled results would need to resolve.

11. What Remains Open

• Single substances: Which randomised study tests a single polyphenol representative against placebo, instead of a mixture or a whole food?
• Clinical endpoints: Which controlled study examines not markers but disease course and events over longer follow-up?
• Absorption: How can gut flora, absorption and measured effect be captured jointly in one study so that the chain becomes traceable?

12. Further Paths

Topics, pathways and chains in which this substance occurs — for all who wish to look beyond the substance.

• Interaction network